References
1. Kazuya Kondo , Kiyoshi Yoshizawa, Masaru Tsuyuguchi, Suguru Kimura, Masayuki Sumitomo, Junji Morita, Takanori Miyoshi, Shoji Sakiyama, Kiyoshi Mukai, Yasumasa Monden. Ann thorac surg 2004(4); 77:1183-8
2. Sonia Berrih-Aknin , Rozen Le Panse. Myasthenia Gravis: A Comprehensive Review of Immune Dysregulation and Etiological Mechanisms. J Autoimmun 2014(8): 52, 90-100
3. E Saka, M A Topcuoglu, B Akkaya, A Galati, M Z Onal, A Vincent. Thymus Changes in anti-MuSK-positive and -Negative Myasthenia Gravis. Neurolohy 2005(9):65,782-783
4. E. K. Deenick and C. S. Ma. The regulation and role of T follicular helper cells in immunity. Immunology 2011; 134(4):361–367
5. Kim L Good-Jacobson, Courtney G Szumilas, Lieping Chen, Arlene H Sharpe, Mary M Tomayko, Mark J Shlomchik. PD-1 Regulates Germinal Center B Cell Survival and the Formation and Affinity of Long-Lived Plasma Cells. Nat Immunol. 2010 June; 11(6): 535–542
6. Yang Song, Lei Zhou, Feng Miao, Gang Chen, Yongjun Zhu, Xue Gao, Yiqing Wang, Liewen Pang, Chongbo Zhao, Xiaotian Sun, Zhiming Chen. Increased Frequency of Thymic T Follicular Helper Cells in Myasthenia Gravis Patients with Thymoma. J Thorac Dis 2016;8(3):314-322
7. Min Zhang, Yongan Zhou, Jun Guo, Hongzeng Li, Feng Tian Li Gong, Xianni Wang, Miao Lan, Zhuyi Li, Wei Zhang. Experimental Neurology 2014; 254: 200 –205
8. Hakiri S, Fukui T, Mori S, Kawaguchi K, Nakamura S, Ozeki N, Kato T, Goto M, Yatabe Y, Yokoi K. Clinicopathologic Features of Thymoma With the Expression of Programmed Death Ligand 1. Ann Thorac Surg. 2019 Feb;107(2):418-424.
9.Prerna Guleria, Nuzhat Husain, Saumya Shukla, Sunil Kumar, Rajinder Parshad, Deepali Jain. PD-L1 Immuno-Expression Assay in Thymomas: Study of 84 Cases and Review of Literature. Annals of Diagnostic Pathology 34 (2018) 135–141
10. Julia A Brown, David M Dorfman, Feng-Rong Ma, Elizabeth L Sullivan, Oliver Munoz, Clive R Wood, Edward A Greenfield, Gordon J Freeman. Blockade of Programmed death-1 Ligands on Dendritic Cells Enhances T Cell Activation and Cytokine Production. J Immunol February 1, 2003, 170 (3) 1257-1266
11. Mohammad Reza Zamani, Saeed Aslani, Arash Salmaninejad, Mohammad Reza Javan, Nima Rezaei. PD-1/PD-L and Autoimmunity: A Growing Relationship. Cellular Immunology 310 (2016) 27–41
12. Yokoi K, Kondo K, Fujimoto K. JLCS medical practice guidelines for thymic tumors: summary of recommendations. Jpn J Clin Oncol 2017; 47:1119–22.
13. Huayu Yang, Xiaoxiang Zhou, Lejia Sun, Yilei Mao. Correlation Between PD-L2 Expression and Clinical Outcome in Solid Cancer Patients: A Meta-Analysis. Front oncol.2019;9:47
14. Kenji Ishiwata, Naohiro Watanabe, Miao Guo, Kei Tomihara, Michael J Brumlik, Hideo Yagita, Drew Pardoll, Lieping Chen, Tahiro Shin. Costimulator B7-DC Attenuates Strong Th2 Responses Induced by Nippostrongylus Brasiliensis. J Immunol. (2010) 184:2086–94
15. Isabelle Rouquette, Estelle Taranchon-Clermont, Julia Gilhodes, Maria-Virginia Bluthgen, Romain Perallon, Lara Chalabreysse, Anne De Muret, Veronique Hofman, Alexander Marx, Marie Parrens, Veronique Secq, Vincent Thomas de Montpreville, Françoise Galateau-Salle, Pierre Brousset, Julie Milia, Nicolas Girard, Benjamin Besse, Thierry Jo Molina, Julien Mazières. Immune Biomarkers in Thymic Epithelial Tumors: Expression Patterns, Prognostic Value and Comparison of Diagnostic Tests for PD-L1. Biomark Res. 2019; 7:28
16. Sukhmani K Padda, Jonathan W Riess, Erich J Schwartz, Lu Tian, Holbrook E Kohrt, Joel W Neal, Robert B West, Heather A Wakelee. Diffuse High Intensity PD-L1 Staining in Thymic Epithelial Tumors. J thorac oncol 2015; 10:500-8
17. Marcello Tiseo, Angela Damato, Lucia Longo, Fausto Barbieri, Federica Bertolini, Alessandro Stefani, Mario Migaldi, Letizia Gnetti, Roberta Camisa, Paola Bordi, Sebastiano Buti, Giulio Rossi.Analysis of a Panel of Druggable Gene Mutations and of ALK and PD-L1 Expression in a Series of Thymic Epithelial Tumors (TETs). Lung cancer 2017; 104:24-30
18. Lorenzo Maggi, Francesca Andreetta, Carlo Antozzi, Fulvio Baggi, Pia Bernasconi, Paola Cavalcante, Ferdinando Cornelio, Giuseppe Muscolino, Lorenzo Novellino, Renato Mantegazza. Thymoma-associated Myasthenia Gravis: Outcome, Clinical and Pathological Correlations in 197 Patients on a 20-year Experience. Journal of Neuroimmunology 201–202 (2008) 237–244
19. Philipp Ströbel, Andrea Bauer, Bernhard Puppe, Til Kraushaar, Axel Krein, Klaus Toyka, Ralf Gold, Michael Semik, Reinhard Kiefer, Wilfred Nix, Berthold Schalke, Hans Konrad Müller-Hermelink, Alexander Marx. Tumor Recurrence and Survival in Patients Treated for Thymomas and Thymic Squamous Cell Carcinomas: A Retrospective Analysis. J. Clin. Oncol. 22,1501-1509
20. Evoli, A., Minisci, C., Di Schino, C., Marsili, F., Punzi, C., Batocchi, A.P., Tonali, P.A., Doglietto, G.B., Granone, P., Trodella, L., Cassano, A., Lauriola, L. Thymoma in patients with MG: characteristics and longterm outcome. Neurology 2002;59, 1844–1850
21. Okumura, M., Ohta,M. ,Tateyama,H.,Nakagawa,K.,Matsumura,A.,Maeda,H., Tada, H., Eimoto, T., Matsuda, H., Masaoka, A.. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 2002; 94, 624–632
22. Kazuya Kondo, Yasumasa Monden. Thymoma and Myasthenia Gravis: A Clinical Study of 1,089 Patients From Japan. Ann Thorac Surg. 2005 Jan;79(1):219-24
23. Jianyong Zou, Chunhua Su, Xueping Lun, Weibing Liu, Weiling Yang, Beilong Zhong, Haoshuai Zhu, Yiyan Lei, Honghe Luo, Zhenguang Chen. Preoperative Anxiety in Patients With Myasthenia Gravis and Risk for Myasthenic Crisis After Extended Transsternal Thymectomy: A CONSORT Study. Medicine (Baltimore). 2016 Mar;95(10):e2828
24. Jianfei Shen, Hongtao Tie, Anyi Xu, Dan Chen, Dehua Ma, Bo Zhang, Chengchu Zhu, Qingchen Wu. Inter-relationship Among Myasthenia Gravis, WHO Histology, and Masaoka Clinical Stage and Effect on Surgical Methods in Patients With Thymoma: A Retrospective Cohort Study. J Thorac Dis. 2018 May;10(5):2981-2990
25. Enrico Ruffini, Pier Luigi Filosso, Claudio Mossetti, Maria Cristina Bruna, Domenico Novero, Patrizia Lista, Caterina Casadio, Alberto Oliaro.Thymoma: Inter-Relationships Among World Health Organization Histology, Masaoka Staging and Myasthenia Gravis and Their Independent Prognostic Significance: A Single-Centre Experience. Eur J Cardiothorac Surg 2011; 40:146-53
26. Alexander Marx , Hans Konrad Müller-Hermelink, Philipp Ströbel. The Role of Thymomas in the Development of Myasthenia Gravis. Ann.N.Y.acad.sci. 2003 998:223-236